Form 4: Marimed Inc. Director David R. Allen Reports Transactions in Company Stock
SEC Form 4 Filing
Director David R. Allen reports acquisition and disposal of Marimed Inc. stock and Restricted Stock Units (RSUs).
Summary
- On June 6, 2024, David R. Allen, a director of Marimed Inc., was granted 75,000 Restricted Stock Units (RSUs) which vest fully on the one-year anniversary of the grant date.
- On June 8, 2024, Allen exercised 75,000 RSUs that vested fully on the one-year anniversary of the June 8, 2023 grant date, converting them into 75,000 shares of common stock.
- Following these transactions, Allen directly owns 0 RSUs and 108,333 shares of common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, and does not inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel.
Stakeholder Impact
- The transactions may have a minor impact on shareholders by slightly increasing the number of outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 06/06/2024 | Grant date of 75,000 Restricted Stock Units (RSUs) which vest fully on the one-year anniversary of the grant date. |
| 06/08/2023 | Grant date of 75,000 Restricted Stock Units (RSUs) which vested fully on the one-year anniversary of the grant date. |
| 06/08/2024 | Exercise of 75,000 RSUs and conversion to common stock. |
| 06/10/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.